HexagonFab raises £1.9 million to accelerate development of its graphene-based ‘Bolt’ system for protein characterization

UK-based developer of graphene-based biological sensors, HexagonFab, recently raised £1.9 million to accelerate development of its novel technology for process monitoring in the biopharmaceutical industry.

The company has developed a portable and affordable instrument – HexagonFab Bolt – which can very rapidly generate biopharma data.

Read More | Graphene-Info
Graphene applications, Graphene Sensors, Medicine, Graphene investing and financials